Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FJNW9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This delivery order, issued on December 9, 2025, represents a firm fixed-price procurement with an ultimate completion date of December 31, 2025. The award was made without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The company will perform work at its Park Ridge, Illinois facility, serving as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy. The parent contract, valued at up to $500 million, was awarded on November 13, 2025, and authorizes DLA to issue multiple delivery orders for a diverse range of pharmaceutical products to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its established performance supplying specialized pharmaceuticals, biologics, and medical consumables to federal agencies, positioning the company as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FJNW9?
SPE2DR26FJNW9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FJNW9 worth?
The government has obligated $16,584 on SPE2DR26FJNW9.
Is contract SPE2DR26FJNW9 an order under another contract?
Yes. SPE2DR26FJNW9 is a delivery order under SPE2DR25D9226, an indefinite delivery contract.
Was contract SPE2DR26FJNW9 competed?
The extent of competition for SPE2DR26FJNW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award